Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지

Soybean isoflavone extract improves glucose tolerance and raises the survival rate in streptozotocin-induced diabetic rats

  • Shim, Jee-Youn (Department of Food Science and Nutrition, Kyungpook National University) ;
  • Kim, Kwang-Ok (Department of Food Science and Nutrition, Kyungpook National University) ;
  • Seo, Bo-Hyun (Department of Food Science and Nutrition, Kyungpook National University) ;
  • Lee, Hye-Sung (Department of Food Science and Nutrition, Kyungpook National University)
  • Published : 2007.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The present study evaluated the effect of various dosages of soybean isoflavone extract on body weight changes, glucose tolerance and liver function in streptozotocin-induced diabetic rats. One group of normal rats (normal control) was fed an AIN-76-based experimental diet and four groups of diabetic rats were fed the same diet supplemented with four different levels of soybean isoflavone extract for seven weeks. The daily dosages of pure isoflavone for four diabetic groups were set to be 0 mg (diabetic control), 0.5 mg (ISO-I), 3.0 mg (ISO-II) and 30.0 mg (ISO-III) per kilogram of body weight, respectively. The daily consumption of isoflavone at the level of 3.0mg per kilogram of body weight resulted in the suppression of body weight loss and increased the survival rate of diabetic animals one and half times compared to that of the diabetic control group. Blood glucose levels in a fasting state and after the oral administration of glucose were significantly lower in the ISO-II group during the oral glucose tolerance test. The ISO-II group showed a tendency to elongate the gastrointestinal transit time. The activity of serum aminotransferases, indicator of liver function, was not negatively affected by any intake level of isoflavone. The present study demonstrated that the soybean isoflavone extract may be beneficial to diabetic animals by improving their glucose tolerance and suppressing weight loss without incurring hepatotoxicity at the daily dosage of 3.0 mg per kg of body weight.

Keywords

References

  1. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW & Toda T (2000). Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844-852 https://doi.org/10.1093/ajcn/72.3.844
  2. Ali AA, Velasquez MT, Hansen CT, Mohamed AI & Bhathena SJ (2005). Modulation of carbohydrate metabolism and peptide hormones by soybean isoflavones and probiotics in obesity and diabetes. J Nutr Biochem 16:693-699 https://doi.org/10.1016/j.jnutbio.2005.03.011
  3. Ali AA, Velasquez MT & Hansen CT (2004). Effects of soy bean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J Nutr Biochem 15:583-590 https://doi.org/10.1016/j.jnutbio.2004.04.005
  4. Anderson JW, Smith BM & Washnock CS (1999). Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr 70:464S-474S https://doi.org/10.1093/ajcn/70.3.464s
  5. Anderson JW, Blake JE, Turner J & Smith BM (1998). Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr 68:1347S-1353S https://doi.org/10.1093/ajcn/68.6.1347S
  6. Aoyama T, Fukui K, Takamatsu K, Hashimoto Y & Yamamoto T (2000). Soy protein isolate and its hydrolysate reduce body fat of dietary obese rats and genetically obese mice (yellow KK). Nutrition 16:349-354 https://doi.org/10.1016/S0899-9007(00)00230-6
  7. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P & Kukreja SC (1996). Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126:161-167 https://doi.org/10.1093/jn/126.1.161
  8. Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y & Esmaill-Zadeh A (2003). Beneficiary effect of dietary soy protein on lowering plasma level lipids and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 57:1292-1294 https://doi.org/10.1038/sj.ejcn.1601688
  9. Baird DD, Umbach DM, Lansdell L, Hughes CL, Setchell KD, Weinberg CR, Haney AF, Wilcox AJ & Mclachlan JA (1995). Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 80:1685-1690 https://doi.org/10.1210/jc.80.5.1685
  10. Bartke A, Peluso MR, Moretz N, Wright C, Bonkowski M, Winters TA, Shanahan MF, Kopchick JJ & Banz WJ (2004). Effects of soy-derived diets on plasma and liver lipids, glucose tolerance, and longevity in normal, long-lived and short-lived mice. Horm Meta Res 36:550-558 https://doi.org/10.1055/s-2004-825796
  11. Bhatena SJ & Velasquez MT (2002). Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76:1191-1201 https://doi.org/10.1093/ajcn/76.6.1191
  12. Bosello O, Cominacini L, Zocca I, Garbin U, Compri R, Davol A & Brunetti L (1998). Short- and long-term effects of hypocaloric diets containing proteins of different sources on plasma lipids and apoproteins of obese subjects. Ann Nutr Metab 32:206-214 https://doi.org/10.1159/000177443
  13. Chen X & Anderson JJB (2001). Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway. Nutr Cancer 41:156-170 https://doi.org/10.1207/S15327914NC41-1&2_22
  14. Constantinou AI, Lantvit D, Hawthorne M, Xu X, van Breemen RB & Pezzuto JM (2001). Chemopreventive effects of soy protein and purified isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr Cancer 41:75-81 https://doi.org/10.1207/S15327914NC41-1&2_10
  15. Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR & Kurzer MS (1999). Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endo Metab 84:3479-3484 https://doi.org/10.1210/jc.84.10.3479
  16. Dyrskog SEU, Jeppesen PB, Colombo M, Abudula R & Hermansen K (2005). Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats. Clin Exper 54:1181-1188
  17. Goodman-Gruen D & Kritz-Silverstein D (2001). Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131:1202-1206
  18. Hermansen K, Sondergaard M, Hoie L, Carstensen M & Brock B (2001). Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diab Care 24:228-233 https://doi.org/10.2337/diacare.24.2.228
  19. Hsu CS, Chiu WC & Yeh SH (2003). Effects of soy isoflavone supplementation on plasma glucose, lipids and antioxidant enzyme activities in streptozotocin-induced diabetic rats. Nutr Res 23:67-75 https://doi.org/10.1016/S0271-5317(02)00386-X
  20. Humphrey LL & Ballard DJ (1990). Renal complications in noninsulin- dependent diabetes mellitus. Clin Ger Med 6, 807-825 https://doi.org/10.1016/S0749-0690(18)30582-2
  21. Hussain M, Banerjee M, Sarkar FH, Djuric Z, Pollak MN, Doerge D, Fontana J, Chinni S, Davis J, Forman J, Wood DP & Kucuk O (2003). Soy isoflavones in the treatment of prostate cancer. Nutr Cancer 47:111-117 https://doi.org/10.1207/s15327914nc4702_1
  22. Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA & Josse RG. (2002). Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76:365-372 https://doi.org/10.1093/ajcn/76.2.365
  23. Kawano-Takahashi Y, Ohminami H & Okuda I (1986). Effect of soy saponins on thioglucose (GTG) induced obesity in mice. Int J Obes 10:293-302
  24. Lajolo FM, Hassimotto NMA & Genovese MI (2005). Isoflavone profile and antioxidant activity of Brazilian soybean varieties. Food Sci Technol Int 11:205-211 https://doi.org/10.1177/1082013205054499
  25. Lavigne C, Marette A & Jacques H (2000). Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 278:491-500 https://doi.org/10.1152/ajpendo.2000.278.3.E491
  26. Lee DS & Lee SH (2001). Genistein, a soy isoflavone, is a potent alpha-glucosidase inhibitor. Fed Eur Biochem Soc letters 501:84-86 https://doi.org/10.1016/S0014-5793(01)02631-X
  27. Lee JS (2006). Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocininduced diabetic rats. Life Sci 79:1578-1584 https://doi.org/10.1016/j.lfs.2006.06.030
  28. Lee SK, Yoon S & Kwon DJ (2000). Estimated isoflavone intake from soy products in Korean middle-aged women. J Korean Soc Food Sci Nutr 29:948-956
  29. Naaz A, Yellayi S & Zakroczymski MA (2003). The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 144:3315-3320 https://doi.org/10.1210/en.2003-0076
  30. Reitman S & Frankel S (1957). A colorimetic method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am J Clin Pathol 2: 56-63
  31. Ren MQ, Kuhn G, Wegner J & Chen J (2001). Isoflavone, substances with multi-biological and clinical properties. Eur J Nutr 40:135-146 https://doi.org/10.1007/PL00007388
  32. Ruiz-Larrea MB, Mohan AR, Paganga G., Miller NJ, Bolwell GP & Rice-Evans CA (1997). Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res 26:63-70 https://doi.org/10.3109/10715769709097785
  33. Satio M (1991). Effect of soy peptides on energy metabolism in obese animals. Nutr Sci Soy Protein 12:91-94
  34. Setchell KD (2001). Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 20:354S-362S https://doi.org/10.1080/07315724.2001.10719168
  35. Setchell KD & Cassidy A (1999). Dietary isoflavones: Biological effects and relevance to human health. J Nutr 129:758S-767S https://doi.org/10.1093/jn/129.3.758S
  36. Somekawa Y, Chiguchi M, Ishibashi T & Aso T (2001). Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. J Obst Gynecol 97: 109-115 https://doi.org/10.1016/S0029-7844(00)01080-2
  37. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S & McGrath BP (2001). Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endo Metab 86:3053-3060 https://doi.org/10.1210/jc.86.7.3053
  38. Teixeira SR, Tappenden KA, Carson L, Jones R, Parabhudesai M, Marsl WP & Erdman JW Jr, (2004). Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 134:1874-80
  39. Taha SA & Wasif MM (1996). Hypoglycemic effect and protein nutritive quality of soy and methionine supplemented whole durum pasta products. Nahrung 40:281-287 https://doi.org/10.1002/food.19960400512
  40. Tham DM, Gardner CD & Haskell WL (1998). Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J Clin Endo Metab 83:2223-2235 https://doi.org/10.1210/jc.83.7.2223
  41. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL & Lamia CA (2000). Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: A multicenter, double-blind, randomized, placebo-controlled study. Menopause 7:236-242 https://doi.org/10.1097/00042192-200007040-00005
  42. Vedavanam K, Srijayanta S, O'Reilly J, Raman A & Wiseman H (1999). Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phyto Res 13:601-608 https://doi.org/10.1002/(SICI)1099-1573(199911)13:7<601::AID-PTR550>3.0.CO;2-O
  43. Wang HJ & Murphy PA (1994). Isoflavone content in commercial soybean foods. J Agric Food Chem 42:1666-1673 https://doi.org/10.1021/jf00044a016
  44. Washburn S, Burke GL, Morgan T & Anthony M (1999). Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in premenopausal women. In B,G, Wrem (Ed.), Menopause 6:7-13
  45. Wei H, Bowen R, Cai Q, Barnes S & Wang Y (1995). Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208:124-130
  46. Yamashita T, Sasahara T, Pomeroy SE, Collier G. & Nestel PG (1998). Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women are improved with weight reduction equally with a meat-based diet and a plant-based diet. Metabolism 47:1308-1314 https://doi.org/10.1016/S0026-0495(98)90297-9
  47. Zhang M, Xie X, Lee AH & Binns CW (2004). Soy isoflavone intake are associated with reduced risk of ovarian cancer in southeast China. Nutr Cancer 49:125-130 https://doi.org/10.1207/s15327914nc4902_2